Scholars Central

Conference abstractPublished 29 Nov 2015

Characterization of the newly developed in vitro chylomicron assay and its potential applications

Authors: Andromeda Nauli

California Northstate University, USA

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The small intestine absorbs lipophilic molecules and transports them in triglyceride-rich lipoproteins. We recently developed a cell-based model capable of producing these lipoproteins. The secreted lipoproteins, namely chylomicrons and very low-density lipoproteins, were isolated by NaCl gradient ultracentrifugation. Their triglycerides, apolipoprotein B, and particle size distribution were subsequently analyzed by enzymatic assay, ELISA/Western blot, and transmission electron microscopy, respectively. Our analysis showed that 21% of the total number of secreted lipoproteins were chylomicrons. Most of the chylomicrons had a diameter of 80-200 nm, and they contained both apolipoprotein B-48 and B-100. In addition, we were able to utilize lentivirus expression system, which is more effective than the regular transfection methods, in upregulating gene expression. Our newly developed model/assay can potentially be used to study dietary fat absorption, chylomicron biogenesis, oral lipophilic drug bioavailability, and intestinal transport of lipophilic molecules

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • BylineArticles whose byline prints “Andromeda Nauli”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels